Abstract
Progressive Muscular Dystrophies (PMDs) are a group of genetic diseases characterized by progressive and irreversible degeneration of skeletal muscles. Mesenchymal stem cells (MSCs) are among the latest therapeutic strategies currently under investigation for PMDs. However, the variables responsible for the successful transplantation of MSCs have not been established yet and the results o…